Comparative effectiveness of branded vs. generic versions of antihypertensive, lipid-lowering and hypoglycemic substances: a population-wide cohort study

Generic medications offer substantial potential cost savings to health systems compared to their branded counterparts. In Europe and the US, they are only approved if they are bioequivalent to the respective originator product. Nevertheless, the lack of clinical outcomes is sometimes used as the rea...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yuxi, Reichardt, Berthold, Dunkler, Daniela, Hronsky, Milan, Winkelmayer, Wolfgang C., Bucsics, Anna, Strohmaier, Susanne, Heinze, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136234/
https://www.ncbi.nlm.nih.gov/pubmed/32249786
http://dx.doi.org/10.1038/s41598-020-62318-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136234/
https://www.ncbi.nlm.nih.gov/pubmed/32249786
http://dx.doi.org/10.1038/s41598-020-62318-y

Ejemplares similares